New Canaan, CT, United States of America

Seymour H Fein

This inventor holds 14 USPTO granted patents and 8 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Allergan, Inc., Serenity Pharmaceuticals LLC, Reprise Biopharmaceutics, LLC. Active years: 2008-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Seymour H Fein. Retrieved from https://idiyas.com/inventor/seymour-h-fein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 8)

% Patents Active = 64.3

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 1.5

ph-index = 6

Forward Citations = 160(Granted Patents)

Location History:

New Canann, CT (US) (2016)
New Canaan, CT (US) (2008 - 2022)

Company Filing History:

Serenity Pharmaceuticals LLC

patents

2 out of 2

Reprise Biopharmaceutics, LLC

5. 1 out of 834,513

Other

patents

Years Active: 2008-2022

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11419914 - Safe desmopressin administration (2022-08-23),

2. 10568927 - Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist (2020-02-25),

3. 10286033 - Methods and compositions comprising desmopressin in combination with an alpha-adrenergic receptor antagonist (2019-05-14),

4. 9925232 - Methods and compositions comprising desmopressin in combination with a 5-alpha reductase inhibitor (2018-03-27),

5. 9814753 - Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist (2017-11-14),

6. 9539302 - Safe desmopressin administration (2017-01-10),

7. 9375530 - Methods and devices for desmopressin drug delivery (2016-06-28),

8. 8399410 - Methods and devices for desmopressin drug delivery (2013-03-19),

9. 8143225 - Pharmaceutical compositions including low dosages of desmopressin (2012-03-27),

10. 7947285 - Methods for preventing post endoscopic retrograde cholangiopancreatography pancreatitis (2011-05-24),

11. 7799761 - Pharmaceutical compositions including low dosages of desmopressin (2010-09-21),

12. 7579321 - Pharmaceutical compositions including low dosages of desmopressin (2009-08-25),

13. 7405203 - Pharmaceutical compositions including low dosages of desmopressin (2008-07-29),

14. 7381698 - Methods for treatment of acute pancreatitis (2008-06-03),

Title: The Innovative Genius of Seymour H. Fein

Introduction

Seymour H. Fein, an acclaimed inventor based in New Canaan, Connecticut, has made significant contributions to the field of medical technology. With a remarkable portfolio of 14 patents, Fein's innovations reflect his dedication to improving health outcomes through safer and more effective treatment methods.

Latest Patents

Among his latest patents is a groundbreaking invention related to Safe Desmopressin Administration. This invention introduces a family of intranasal spray dispensers designed for administering uniform low doses of desmopressin, enabling safe antidiuresis in human patients. The dispensers are particularly beneficial for treating conditions such as nocturia, primary nocturnal enuresis, incontinence, urinary frequency, and diabetes insipidus. Moreover, they facilitate safe temporary suppression of urine production, enhancing convenience in voiding control and improving overall health outcomes.

Another of Fein's noteworthy patents involves methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist. This innovative approach offers new avenues for treating nocturia and other urinary frequency disorders, showcasing Fein's commitment to advancing medical therapies.

Career Highlights

Throughout his career, Seymour H. Fein has collaborated with prominent companies like Allergan, Inc. and Serenity Pharmaceuticals LLC. His work at these organizations not only underscores his expertise but also highlights his ability to translate innovative ideas into practical applications that address patient needs.

Collaborations

Fein has partnered with esteemed colleagues such as Samuel Herschkowitz and Edward D. Purich, demonstrating the importance of collaboration in the development of innovative healthcare solutions. Together, they have advanced research and made strides in enhancing patient care through their collective expertise.

Conclusion

Seymour H. Fein stands out as a prominent inventor dedicated to improving medical treatment through his innovative inventions. With 14 patents to his name, Fein continues to impact the field positively, paving the way for future advancements in healthcare technology. His work exemplifies the profound effect that passionate inventors can have on society's health and well-being.

Profile summary based on public USPTO records.